NSEBSE
NSEBSE
noteThere is a 15-minute delay in the prices. To check out the live prices, log in to your Ventura account or open one today.
1D
1W
1M
1Y
3Y
5Y
Max
Open658
High665.3
Low647.6
Prev. Close657.1
Avg. Traded Price656.3
Volume2,71,842

MARKET DEPTH

info2
Total bid1,08,295.00
Total ask1,69,831.00
OrdersQtyBid
13648.15
214648.1
226648.05
226648
263647.95
AskQtyOrders
648.4458
648.45590
648.5353
648.557100
648.613325

HIGH/LOW

info2
1d
1w
1m
3m
52w

LOW/HIGH

646.95a minute ago
665.303 hours ago
arrow

LOWER/UPPER CIRCUITS

591.40
722.80
arrow
Syngene International Ltd Stock performance
arrow

KEY OBSERVATIONS

info
positive
negative
neutral
noteAnnual Revenue,rose 3.77%, in the last year to ₹3,714.2 Cr. Its sector's average revenue growth for the last fiscal year was 10.73%.
noteQuarterly Revenue,rose 2.2% YoY to ₹926 Cr. Its sector's average revenue growth YoY for the quarter was 13.04%.
noteInterest Coverage Ratio,is 20.97, higher than 1.5. This means that it is able to meet its interest payments comfortably with its earnings (EBIT).
View more

LONG-TERM PRICE ANALYSIS

info
Stock return5Y CAGR : 18.74%
Net profit growth 5Y CAGR : 8.99%
Syngene International Limited, incorporated in 1993, is an internationally reputed contract research and manufacturing organization, which supports RD programs from lead generation to clinical supplies. The company’s multi-disciplinary skills in integrated drug discovery and development include capabilities in medicinal chemistry, biology, in vivo pharmacology, toxicology, custom synthesis, process RD, cGMP manufacturing, formulation and analytical development along with Clinical development services. The company has state-of-the-art research facilities certified with ISO 9001:2008, ISO 14001:2004, and OHSAS 18001:2007. The company’s animal facilities are GLP certified by the Indian authorities and AAALAC accredited.
personal

Grow your wealth with more research recommendations

+91